Head of U.S. Health Economics & Value Assessment (HEVA)

Job Title: Head of U.S. Health Economics & Value Assessment (HEVA) 

Location: Cambridge, MA, Morristown, NJ

About the Job

Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs.

The Head of U.S. Health Economics & Value Assessment (HEVA) is a senior strategic and scientific leader responsible for shaping and executing the U.S. HEVA strategy for Sanofi’s Specialty Care portfolio, the company’s largest and most complex market and region.

Reporting to the Global Head of HEVA, Specialty Care, with a dotted-line accountability to the U.S. Specialty Care Business (Value & Access or U.S. Head), this role leads a team of U.S. HEVA Therapeutic Area (TA) Leads who deliver the evidence and insights needed to ensure access, inform policy, and demonstrate value throughout the product lifecycle (from launch through post-launch optimization).

The U.S. HEVA Head is a strategic business partner and thought leader—translating global evidence into US regional impact, delivering US specific evidence generation and dissemination, shaping payer and policymaker dialogue, and ensuring HEVA evidence directly influence pricing, access, and policy decisions. This is a market-facing, enterprise-critical leadership role that ensures Sanofi’s evidence translates into real-world impact in its most commercially significant region.

About Sanofi:
We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives.

Main Responsibilities:

Strategic Leadership and Market Impact

• Define and execute the U.S. HEVA strategy across all Specialty Care therapeutic areas, aligned with global HEOR, U.S. Medical, and Commercial priorities.

• Serve as a member of both the Global HEOR Leadership Team and the U.S. Specialty Care Leadership Team, ensuring full alignment and integration between global and US regional strategies.

• Translate HEVA evidence into business and policy impact—driving payer engagement, value positioning, and access strategies.

• Anticipate and proactively address U.S. policy and reimbursement dynamics (eg, PDAB, ICER, IRS, MFN) through strategic evidence planning and engagement.

• Represent Sanofi externally as a U.S. HEVA thought leader, advancing the role of evidence in access, policy, and clinical decision-making.

Evidence Generation and Dissemination

• Oversee design and execution of U.S.-focused HEVA inclusive of RWE program that demonstrate product value across diverse payer and healthcare systems.

• Lead launch excellence and post-launch US specific HEVA strategies, ensuring evidence generation aligns with U.S. access, pricing, and policy needs.

• Develop and guide compliant and impactful US evidence dissemination pathways (eg, HCEI, PIE, CFL, etc.)—including publications, payer dossiers, field materials, and digital platforms.

• Partner with U.S. Medical Affairs/Value & Access to ensure appropriate use of HEOR evidence in field communications and training.

• Champion data-driven storytelling that enhances HEVA’s impact and visibility in internal and external forums.

Policy, Payer, and Stakeholder Engagement

• Collaborate with Value & Access, US Medical Affairs, and Policy teams to deliver evidence that informs value frameworks, PDAB and ICER responses, value-based contracting strategies, etc.

• Partner with State Government Affairs and external advocacy organizations to shape emerging access and affordability policies.

• Lead engagement with key US policy stakeholders (eg, ICER) to represent Sanofi’s HEVA perspectives and scientific rigor.

• Support Sanofi’s external advocacy, guidelines, and evidence education initiatives to shape practice and reimbursement in the US.

People, Culture, and Organizational Leadership

• Lead and develop a high-performing U.S. HEVA team, fostering scientific excellence, collaboration, and accountability.

• Empower U.S. TA Leads to act as strategic partners to the business and thought leaders in their therapeutic areas.

• Promote a culture of innovation, inclusion, and